Want to see INBP full AI Analyst Report?
Integrated BioPharma (INBP) Income Statement
Integrated BioPharma Income Statement
Last quarter (Q4 2026), Integrated BioPharma's total revenue was $9.80M, a decrease of 30.89% from the same quarter last year. In Q4, Integrated BioPharma's net income was $-1.37M. See Integrated BioPharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 43.87M | $ 54.35M | $ 50.32M | $ 50.67M | $ 56.25M | |
| $ 800.00K | $ 5.56M | $ 3.88M | $ 4.06M | $ 6.55M | |
| $ 3.50M | $ 3.54M | $ 3.63M | $ 3.94M | $ 3.81M | |
| Depreciation and Amortization | $ 1.39M | $ 1.27M | $ 1.22M | $ 1.15M | $ 834.00K |
| $ -1.32M | $ 3.38M | $ 1.47M | $ 1.27M | $ 3.56M | |
| $ -2.71M | $ 2.02M | $ 251.00K | $ 120.00K | $ 1.97M | |
| $ 142.00K | $ 42.00K | $ 17.00K | $ -20.00K | $ -148.00K | |
| $ -2.56M | $ 2.06M | $ 268.00K | $ 100.00K | $ 2.60M | |
| $ -2.84M | $ 808.00K | $ 112.00K | $ -34.00K | $ 3.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.09 | $ 0.03 | $ 0.00 | $ -0.00 | $ 0.13 |
| Diluted EPS | $ -0.09 | $ 0.03 | $ 0.00 | $ -0.00 | $ 0.12 |
| Weighted Average Shares Outstanding | 31.06M | 30.30M | 30.07M | 29.95M | 29.84M |
| Weighted Average Shares Outstanding (Diluted) | 31.06M | 31.17M | 30.87M | 29.95M | 32.32M |
Currency in USD
